Loading
Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso Stock: price and insider trades · Italy
Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso: what insiders have been doing
Insider filings for Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso are scarce in the Consob feed, the latest one published on 26 May 2023. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Consob and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,114 of 24,148 companies
61.8
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.00
Analyst consensus
3 analysts1.00/5
€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.7x
PER (forward)27.1x
P/Book10.7x
Beta0.17
Balance sheet & cash
Market cap€794.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions17.2%
Last declaration on 26 May 2023
About Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso
Pharmanutra is a company specializing in the health and pharmaceutical sector, known for its innovative products. It is listed on the XMIL market and recently collaborated with Fernando Alonso to promote its Cetilar brand.
